SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
19-Mar-24 4:05 PM View: | Denner Alexander J Director 10% Owner | Ironwood Pharmaceuticals Inc (IRWD) | 15-Mar-24 | Grant | 1,662 | -- | -- | < 1% 16.51M to 16.51M | |
12-Mar-24 4:05 PM View: | McCourt Thomas A Chief Executive Officer Director | Ironwood Pharmaceuticals Inc (IRWD) | 08-Mar-24 | Option Exercise | 120,298 | -- | -- | 11% 1.1M to 1.22M | |
12-Mar-24 4:05 PM View: | John Minardo Chief Legal Officer | Ironwood Pharmaceuticals Inc (IRWD) | 08-Mar-24 | Option Exercise | 32,752 | -- | -- | 12% 279.22K to 311.98K | |
12-Mar-24 4:05 PM View: | Davis Andrew SVP, Chief Business Officer | Ironwood Pharmaceuticals Inc (IRWD) | 08-Mar-24 | Option Exercise | 37,120 | -- | -- | 14% 273.64K to 310.76K | |
12-Mar-24 4:05 PM View: | Shetzline Michael CMO,SVP,Head-Res&Drug | Ironwood Pharmaceuticals Inc (IRWD) | 08-Mar-24 | Option Exercise | 34,936 | -- | -- | 9% 394.91K to 429.85K | |
12-Mar-24 4:05 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 08-Mar-24 | Option Exercise | 37,120 | -- | -- | 12% 301.73K to 338.85K | |
08-Mar-24 4:05 PM View: | Duane Jon R Director | Ironwood Pharmaceuticals Inc (IRWD) | 06-Mar-24 | Private Purchase | 6,920 | $8.70 | $60,204.00 | 6% 114.11K to 121.03K | |
07-Mar-24 4:05 PM View: | McCourt Thomas A Chief Executive Officer Director | Ironwood Pharmaceuticals Inc (IRWD) | 05-Mar-24 | Grant | 264,876 | -- | -- | 32% 832.77K to 1.1M | |
06-Mar-24 4:05 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 04-Mar-24 | Private Purchase | 10,684 | $9.38 | $100,216.00 | 4% 291.05K to 301.73K | |
14-Feb-24 8:42 PM View: | Davis Andrew SVP, Chief Business Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Sale | 9,846 | $15.24 | $150,053.00 | (3%) 283.48K to 273.64K | |
14-Feb-24 8:53 PM View: | Shetzline Michael CMO,SVP,Head-Res&Drug | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Sale | 38,618 | $15.24 | $588,538.00 | (9%) 433.53K to 394.91K | |
14-Feb-24 8:50 PM View: | Silver Ronald Principal Accounting Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Grant | 27,213 | -- | -- | 19% 142.17K to 169.38K | |
14-Feb-24 8:35 PM View: | McCourt Thomas A Chief Executive Officer Director | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Private Sale | 177,164 | $15.24 | $2,699,980.00 | (18%) 1.01M to 832.77K | |
14-Feb-24 8:50 PM View: | Silver Ronald Principal Accounting Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Sale | 7,908 | $15.24 | $120,518.00 | (5%) 169.38K to 161.48K | |
14-Feb-24 9:01 PM View: | John Minardo Chief Legal Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Grant | 54,427 | -- | -- | 20% 272.18K to 326.6K | |
14-Feb-24 8:42 PM View: | Davis Andrew SVP, Chief Business Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Grant | 65,312 | -- | -- | 30% 218.17K to 283.48K | |
14-Feb-24 8:53 PM View: | Shetzline Michael CMO,SVP,Head-Res&Drug | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Grant | 54,427 | -- | -- | 14% 379.1K to 433.53K | |
14-Feb-24 8:39 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Grant | 65,312 | -- | -- | 29% 225.74K to 291.05K | |
14-Feb-24 9:01 PM View: | John Minardo Chief Legal Officer | Ironwood Pharmaceuticals Inc (IRWD) | 12-Feb-24 | Sale | 47,380 | $15.24 | $722,071.00 | (15%) 326.6K to 279.22K | |
12-Feb-24 4:05 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 08-Feb-24 | Payment of Exercise | 41,332 | $14.90 | $615,847.00 | (15%) 267.07K to 225.74K | |
19-Jan-24 4:05 PM View: | McCourt Thomas A Chief Executive Officer Director | Ironwood Pharmaceuticals Inc (IRWD) | 17-Jan-24 | Grant | 249,617 | -- | -- | 33% 760.32K to 1.01M | |
19-Jan-24 4:05 PM View: | John Minardo Chief Legal Officer | Ironwood Pharmaceuticals Inc (IRWD) | 17-Jan-24 | Grant | 79,981 | -- | -- | 42% 192.19K to 272.18K | |
19-Jan-24 4:05 PM View: | Shetzline Michael CMO,SVP,Head-Res&Drug | Ironwood Pharmaceuticals Inc (IRWD) | 17-Jan-24 | Grant | 57,971 | -- | -- | 18% 321.13K to 379.1K | |
19-Jan-24 4:05 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 17-Jan-24 | Grant | 85,000 | -- | -- | 47% 182.07K to 267.07K | |
19-Dec-23 4:05 PM View: | Denner Alexander J Director 10% Owner | Ironwood Pharmaceuticals Inc (IRWD) | 15-Dec-23 | Grant | 1,347 | -- | -- | < 1% 16.51M to 16.51M | |
19-Dec-23 4:05 PM View: | Moukheibir Catherine Director | Ironwood Pharmaceuticals Inc (IRWD) | 15-Dec-23 | Grant | 1,572 | -- | -- | 1% 127.06K to 128.63K | |
18-Dec-23 4:09 PM View: | Kessler Marla L Director | Ironwood Pharmaceuticals Inc (IRWD) | 14-Dec-23 | Market Sale (Planned) | 9,926 | $11.19 | $111,072.00 | (9%) 106.5K to 96.57K | (6%) |
22-Nov-23 4:05 PM View: | Davis Andrew SVP, Chief Business Officer | Ironwood Pharmaceuticals Inc (IRWD) | 20-Nov-23 | Sale | 3,287 | $9.69 | $31,851.00 | (1%) 220.66K to 217.37K | |
20-Nov-23 4:05 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 16-Nov-23 | Payment of Exercise | 6,661 | $9.44 | $62,879.80 | (4%) 188.73K to 182.07K | |
19-Sep-23 5:05 PM View: | Moukheibir Catherine Director | Ironwood Pharmaceuticals Inc (IRWD) | 15-Sep-23 | Grant | 2,098 | -- | -- | 2% 124.96K to 127.06K | |
19-Sep-23 5:04 PM View: | Denner Alexander J Director 10% Owner | Ironwood Pharmaceuticals Inc (IRWD) | 15-Sep-23 | Grant | 1,798 | -- | -- | < 1% 16.51M to 16.51M | |
18-Sep-23 5:07 PM View: | Emany Sravan Kumar SVP, Chief Financial Officer | Ironwood Pharmaceuticals Inc (IRWD) | 15-Sep-23 | Private Purchase | 36,072 | $8.32 | $300,119.00 | 24% 152.66K to 188.73K | |
31-Aug-23 4:05 PM View: | Silver Ronald Principal Accounting Officer | Ironwood Pharmaceuticals Inc (IRWD) | 29-Aug-23 | Grant | 8,000 | -- | -- | 6% 134.17K to 142.17K | |
16-Aug-23 4:21 PM View: | Silver Ronald Principal Accounting Officer | Ironwood Pharmaceuticals Inc (IRWD) | 14-Aug-23 | Sale | 1,976 | $10.04 | $19,839.00 | (1%) 136.15K to 134.17K | |
16-Aug-23 4:20 PM View: | John Minardo Chief Legal Officer | Ironwood Pharmaceuticals Inc (IRWD) | 14-Aug-23 | Sale | 7,045 | $10.04 | $70,731.80 | (4%) 199.24K to 192.19K | |
22-Jun-23 5:29 PM View: | McHugh Julie Director | Ironwood Pharmaceuticals Inc (IRWD) | 20-Jun-23 | Grant | 22,350 | -- | -- | 16% 139.94K to 162.29K | |
22-Jun-23 5:30 PM View: | Moukheibir Catherine Director | Ironwood Pharmaceuticals Inc (IRWD) | 20-Jun-23 | Grant | 22,350 | -- | -- | 22% 102.61K to 124.96K | |
22-Jun-23 5:31 PM View: | Shepard Jay Director | Ironwood Pharmaceuticals Inc (IRWD) | 20-Jun-23 | Grant | 22,350 | -- | -- | 28% 79.89K to 102.24K | |
22-Jun-23 5:29 PM View: | Kessler Marla L Director | Ironwood Pharmaceuticals Inc (IRWD) | 20-Jun-23 | Grant | 22,350 | -- | -- | 27% 84.15K to 106.5K | |
22-Jun-23 5:26 PM View: | Denner Alexander J Director 10% Owner | Ironwood Pharmaceuticals Inc (IRWD) | 20-Jun-23 | Grant | 22,350 | -- | -- | < 1% 16.48M to 16.51M | |
22-Jun-23 5:26 PM View: | Currie Mark G Director | Ironwood Pharmaceuticals Inc (IRWD) | 20-Jun-23 | Grant | 22,350 | -- | -- | 4% 521.76K to 544.11K | |
22-Jun-23 5:28 PM View: | Duane Jon R Director | Ironwood Pharmaceuticals Inc (IRWD) | 20-Jun-23 | Grant | 22,350 | -- | -- | 24% 91.76K to 114.11K | |
22-Jun-23 5:27 PM View: | Dreyfus Andrew Director | Ironwood Pharmaceuticals Inc (IRWD) | 20-Jun-23 | Grant | 22,350 | -- | -- | 15% 146.63K to 168.98K | |
20-Jun-23 4:05 PM View: | Denner Alexander J Director 10% Owner | Ironwood Pharmaceuticals Inc (IRWD) | 15-Jun-23 | Grant | 1,359 | -- | -- | < 1% 16.48M to 16.48M | |
20-Jun-23 4:05 PM View: | Moukheibir Catherine Director | Ironwood Pharmaceuticals Inc (IRWD) | 15-Jun-23 | Grant | 1,586 | -- | -- | 2% 101.03K to 102.61K | |
01-Jun-23 5:45 PM View: | McCourt Thomas A Chief Executive Officer Director | Ironwood Pharmaceuticals Inc (IRWD) | 30-May-23 | Market Sale (Planned) | 26,632 | $10.70 | $284,962.00 | (3%) 784.92K to 758.28K | (11%) |
24-May-23 10:00 PM View: | Davis Andrew SVP, Chief Business Officer | Ironwood Pharmaceuticals Inc (IRWD) | 22-May-23 | Sale | 6,305 | $10.12 | $63,806.60 | (3%) 225.63K to 219.33K | |
24-May-23 4:05 PM View: | Shetzline Michael CMO,SVP,Head-Res&Drug | Ironwood Pharmaceuticals Inc (IRWD) | 22-May-23 | Sale | 10,324 | $10.12 | $104,479.00 | (3%) 331.45K to 321.13K | |
24-May-23 10:00 PM View: | McCourt Thomas A Chief Executive Officer Director | Ironwood Pharmaceuticals Inc (IRWD) | 22-May-23 | Sale | 36,000 | $10.12 | $364,320.00 | (4%) 820.92K to 784.92K | |
10-May-23 4:05 PM View: | McCourt Thomas A Chief Executive Officer Director | Ironwood Pharmaceuticals Inc (IRWD) | 08-May-23 | Market Sale (Planned) | 21,148 | $10.62 | $224,592.00 | (3%) 842.06K to 820.92K | (12%) |